Quick Takeaways
- BML Investment Partners, L.P. filed SCHEDULE 13G for Atea Pharmaceuticals, Inc. Common Stock (AVIR).
- Disclosed ownership: 9.9%.
- Date of event: 31 Dec 2025.
BML Investment Partners, L.P. - 31 Dec 2025 SCHEDULE 13G Report for Atea Pharmaceuticals, Inc. Common Stock (AVIR)
- Filing Manager
- BML Investment Partners, L.P.
- Reporting Manager
- Leonard Braden Michael
- Symbol
- AVIR
- Shares outstanding
- 78,888,889 shares
- Disclosed Ownership
- 7,810,000 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G
- Filing time
- 09 Feb 2026, 14:02:27 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 16 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"BML Investment Partners, L.P. disclosed 9.9% ownership in Atea Pharmaceuticals, Inc. Common Stock (AVIR) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 16 Dec 2024.
- Current filing was accepted on 09 Feb 2026, 14:02.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BML Investment Partners, L.P. | 9.6% | 7,490,000 | 0 | 7,490,000 | Braden M Leonard | BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member | |
| Leonard Braden Michael | 9.9% | 7,810,000 | 320,000 | 7,490,000 | Braden M Leonard | Leonard Braden Michael |